These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10933044)

  • 1. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging.
    Galons JP; Altbach MI; Paine-Murrieta GD; Taylor CW; Gillies RJ
    Neoplasia; 1999 Jun; 1(2):113-7. PubMed ID: 10933044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.
    Jennings D; Hatton BN; Guo J; Galons JP; Trouard TP; Raghunand N; Marshall J; Gillies RJ
    Neoplasia; 2002; 4(3):255-62. PubMed ID: 11988845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis.
    Pang D; Kocherginsky M; Krausz T; Kim SY; Conzen SD
    Cancer Biol Ther; 2006 Aug; 5(8):933-40. PubMed ID: 16775428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
    Vredenburg MR; Ojima I; Veith J; Pera P; Kee K; Cabral F; Sharma A; Kanter P; Greco WR; Bernacki RJ
    J Natl Cancer Inst; 2001 Aug; 93(16):1234-45. PubMed ID: 11504769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
    Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G
    J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
    Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
    Zhang L; Lau YK; Xia W; Hortobagyi GN; Hung MC
    Clin Cancer Res; 1999 Feb; 5(2):343-53. PubMed ID: 10037184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
    Chen SY; Hu SS; Dong Q; Cai JX; Zhang WP; Sun JY; Wang TT; Xie J; He HR; Xing JF; Lu J; Dong YL
    Asian Pac J Cancer Prev; 2013; 14(10):6135-40. PubMed ID: 24289639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors.
    Sui M; Chen F; Chen Z; Fan W
    Int J Cancer; 2006 Aug; 119(3):712-7. PubMed ID: 16496381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?
    Miers L; Lamborn K; Yuan A; Richman C; Natarajan A; DeNardo S; DeNardo G
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7158s-7163s. PubMed ID: 16203816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
    Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of docetaxel-resistant breast cancer responsive to paclitaxel therapy].
    Oura S; Tanino H; Yoshimasu T; Sakurai T; Nakamura T; Kokawa Y; Matsuyama K; Naito Y
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):511-4. PubMed ID: 11329786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents.
    Miller IS; Shiels LP; Conroy E; Connor K; Dicker P; Gallagher WM; Donovan NO; Kerbel RS; Crown J; Byrne AT
    Sci Rep; 2019 Jun; 9(1):9204. PubMed ID: 31235775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.
    Mignion L; Danhier P; Magat J; Porporato PE; Masquelier J; Gregoire V; Muccioli GG; Sonveaux P; Gallez B; Jordan BF
    Int J Cancer; 2016 Apr; 138(8):2043-9. PubMed ID: 26595604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
    Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence?
    Gehrmann M; Schmidt M; Brase JC; Roos P; Hengstler JG
    Pharmacogenomics; 2008 Jul; 9(7):969-74. PubMed ID: 18597657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Detection of Treatment-Induced Mitotic Arrest Using Temporal Diffusion Magnetic Resonance Spectroscopy.
    Jiang X; Li H; Zhao P; Xie J; Khabele D; Xu J; Gore JC
    Neoplasia; 2016 Jun; 18(6):387-97. PubMed ID: 27292027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.